Arrowstreet Capital, Limited Partnership Cumberland Pharmaceuticals Inc Transaction History

Arrowstreet Capital, Limited Partnership

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$1.93 - $3.03 $34,012 - $53,397	-17,623 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$2.56 - $4.98 $9,254 - $18,002	-3,615 Reduced 17.02%	17,623 $50,000
Q4 2021 Feb 14, 2022	BUY	$2.2 - $6.94 $46,723 - $147,391	21,238 New	21,238 $99,000
Q3 2021 Nov 12, 2021	SELL	$2.66 - $3.45 $28,462 - $36,915	-10,700 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$2.99 - $3.58 $31,993 - $38,306	10,700 New	10,700 $32,000

1.97M

44.2K

Ticker CPIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 14,661,900
Market Cap $34.3M
Description
Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company, focuses on the acquisition, development, and commercialization of prescription products for hospital acute care, gastroenterology, rheumatology, and oncology in the United States and internationally. The company offers Acetadote, an injection for the treatment of acetaminophen ...

Get notified when there are updates to the investment portfolio of Arrowstreet Capital, Limited Partnership, based on Form 13F filings with the SEC.

Stay updated on Arrowstreet Capital, Limited Partnership with notifications on news.